AnaSpec is excited to announce the release of 4 more new phosphospecific anti-Tau antibodies. This represents the industry’s largest collection of anti-Tau antibodies - 17 phosphospecific and 9 non-phosphospecific antibodies. AnaSpec’s expertise in phosphopeptide synthesis combined with... - November 23, 2008 - AnaSpec, Inc.

AnaSpec and Shanghai Universal Biotech Company today announced a non-exclusive distributor agreement that will allow Shanghai Universal Biotech Company to distribute AnaSpec’s catalog and custom products throughout China. - November 22, 2008 - AnaSpec, Inc.

In response to increased demand for GMP peptide production, AnaSpec has established a new facility dedicated to GMP manufacturing. Located adjacent to its current San Jose, California-based headquarters, the expansion provides an additional 5000 sq. ft. of dedicated GMP space including two class 10,000... - November 16, 2008 - AnaSpec, Inc.

AnaSpec offers coelenterazine and several synthetic coelenterazine analogs for reconstituting aequorin in cells that have been transfected with apoaequorin cDNA. - November 14, 2008 - AnaSpec, Inc.

AnaSpec is pleased to announce the release of the improved AnaTagTM APC, B-PE and R-PE Labeling Kits. Labeling of antibodies can be both tedious and time-consuming. Without the use of proper techniques and reagents, the conjugation may result in suboptimal or no labeling. AnaSpec’s improved APC,... - November 12, 2008 - AnaSpec, Inc.

Calcium plays a vital role in the regulation of cardiac contractility, growth and gene expression; consequently, calcium measurement is critical in numerous biological investigations. Fluorescent probes that show spectral responses upon Ca2+ binding have enabled researchers to investigate changes in... - November 05, 2008 - AnaSpec, Inc.

Millions of women baby boomers are suffering from hot flashes. Dr. Patricia Beckstead has devoted a website and product line to helping those women get menopause relief without drugs. - November 03, 2008 - Freedom from Menopause® and PMS

Mitochondrial DNA Testing, also known as MtDNA, is the preferred method of sampling used by forensic scientists around the world. MtDNA is extremely abundant. In any human cell, you can expect to find hundreds of copies of MtDNA, and only two copies of the DNA in the nucleus. MtDNA is a resilient source... - October 29, 2008 - Bio-Synthesis Inc.

Protein kinase D (PKD belongs to the calcium calmodulin superfamily of kinases (2-3). - October 23, 2008 - AnaSpec, Inc.

MMPs are key players in normal and pathological processes, including embryogenesis, wound healing, inflammation, arthritis, and cancer. - October 18, 2008 - AnaSpec, Inc.

AnaSpec published a technical article entitled, “Sensitive FRET Assays Aid Drug Discovery” in the August edition of Biophotonics International. - October 16, 2008 - AnaSpec, Inc.

The core histones (H2A, H2B, H3 and H4) act as spools around which DNA winds. Covalent modification on the amino terminal of the core histones through de/acetylation, de/methylation and de/phosphorylation affect chromatin structure and exquisitely regulate gene expression.1-3 Histone hyperacetylation... - October 11, 2008 - AnaSpec, Inc.

Copper (I) species are powerful catalysts for the formation of 1,2,3-triazoles from azides and alkynes. The general thermodynamic instability of Cu(I) however, results in easy oxidation to Cu(II) and/or disproportionation to Cu(0) and Cu(II).1 TBTA, Tris-[(1-benzyl-1H-1,2,3-triazol-4-yl) methyl]amine,... - September 24, 2008 - AnaSpec, Inc.

Genomic Nanosystems, LLC, today announced that it has granted an exclusive license to Sequenom, Inc. (Nasdaq: SQNM) for the right to use Digital PCR in noninvasive prenatal research and diagnostics on a technology, platform and sample independent basis, and has granted the exclusive right to use digital... - September 22, 2008 - Genomic Nanosystems

Since its inception in 1993, AnaSpec has provided drug discovery reagents to some of the world’s largest biotech, pharmaceutical, and academic research institutions. - September 21, 2008 - AnaSpec, Inc.

AnaSpec announced today that BD Biosciences, a business segment of BD (Becton Dickinson and Company), has chosen it to manufacture and supply the BD™ H7, Calcein AM and DiIC12(3) Fluorescent Dyes. “BD Biosciences has a tremendous reputation in the industry for innovative products of the... - September 19, 2008 - AnaSpec, Inc.

AnaSpec has introduced its latest collection of streptavidins labeled with its patented HiLyte Fluor(TM) and HiLytePlus(TM) dyes which promise brighter fluorescence and better photostability compared to FITC and Cyâ dyes. - September 18, 2008 - AnaSpec, Inc.

AnaSpec and RayBiotech today announced a licensing agreement that will allow RayBiotech to label antibodies with AnaSpec HiLytePlus™ and HiLyte Fluor™ dyes and integrate into protein and antibody arrays. HiLytePlus™ and HiLyte Fluor™ are AnaSpec's proprietary series of high performance... - September 17, 2008 - AnaSpec, Inc.

AnaSpec and Cyclex Co. Ltd. today announced a licensing agreement that will allow AnaSpec to make, use, and sell deacetylase activity assay kits and the related products as covered by Cyclex’s patent # ‘s EP 1243658, US 7033778, US 7256013. "We are pleased to partner with Cyclex in... - September 14, 2008 - AnaSpec, Inc.

Protein kinases are a transferase family of self-regulatory enzymes that catalyze the phosphorylation of other proteins by covalently attaching phosphate groups to them, using ATP as a phosphate donor. Reversible protein phosphorylation-dephosphorylation has a principal role in the regulation of essentially... - September 11, 2008 - AnaSpec, Inc.

Expanding on its world-class collection of MOG peptides and assay kits, AnaSpec is pleased to announce the release of 3 MOG recombinant proteins, for human, mouse and rat. These proteins, with sequences corresponding to human, mouse and rat extracellular domain, together with a 6x His tag were expressed... - September 10, 2008 - AnaSpec, Inc.

At the 2008 International Conference for Alzheimer’s Disease, the VU University Medical Centre and Lund University presented a joint poster entitled, “Aβ1-42 binding and uptake by primary human astrocytes in vitro: Effects of a1-Antichymotrypsin.” The authors of the study were... - August 31, 2008 - AnaSpec, Inc.

AnaSpec has announced the release of two antibodies for growth secretagogue receptor (GHSR). One antibody targets the N-terminus and the other an internal sequence. GHSR is a G protein-coupled receptor with seven transmembrane domains and is primarily expressed in hypothalamus and pituitary glands (1-4). GHSR... - August 30, 2008 - AnaSpec, Inc.

AnaSpec and UW TechTransfer today announced a licensing agreement that will allow AnaSpec to make, use, and sell Protein Tyrosine Phosphatase Substrates as covered by UW’s patent # 5,739,278 entitled “Compositions for Protein Tyrosine Phosphatases.” "We are pleased to partner... - August 29, 2008 - AnaSpec, Inc.

AnaSpec and Biocore Pty Ltd today announced a non-exclusive distributor agreement that will allow Biocore Pty Ltd to distribute AnaSpec’s catalog and custom products throughout Australia. AnaSpec’s Director of Sales & Marketing, Violeta Rajkovska, noted, “AnaSpec is pleased to... - August 14, 2008 - AnaSpec, Inc.

AnaSpec is pleased to introduce GO Peptides™, the next evolution in peptide tools. - August 13, 2008 - AnaSpec, Inc.

Matrix metalloproteinases (MMPs) belong to a family of secreted or membrane-associated proteins capable of digesting extracellular matrix components. The importance of MMPs in tumor development and invasion as well as other diseases is well known. AnaSpec has introduced the SensoLyteTM 570 Generic MMP... - August 09, 2008 - AnaSpec, Inc.

AnaSpec and Novus Biologicals today announced a licensing agreement that will allow Novus Biologicals to label Novus antibodies with AnaSpec HiLytePlus™ and HiLyte Fluor™ dyes. HiLytePlus™ and HiLyte Fluor™ are AnaSpec's proprietary series of high performance fluorescent dyes... - July 30, 2008 - AnaSpec, Inc.

AnaSpec now offers custom synthesis service of peptide-aminoluciferin substrates. - July 23, 2008 - AnaSpec, Inc.

AnaSpec has introduced its latest series of PAR peptides. - July 09, 2008 - AnaSpec, Inc.

AnaSpec has introduced two keratin antibodies that recognize both the intact and caspase digested N-terminal of K18 and K19 at Asp237. These antibodies are useful tools for studying keratin dynamics in mice undergoing hepatocyte apoptosis, patients with cirrhosis, and also in apoptotic cells of various... - July 04, 2008 - AnaSpec, Inc.

Histone deacetylase (HDAC) enzymes modulate gene expression through the deacetylation of lysine residues on histone proteins and act as transcriptional repressors of genes. Based on their role in cell cycling, apoptosis and differentiation, HDACs have been chosen as therapeutic targets for the treatment... - June 27, 2008 - AnaSpec, Inc.

The formulation development company’s services are led by an industry pioneer. - June 22, 2008 - Xcelience, LLC

The innovative technique of hydrocarbon stapling in peptides is introducing valuable new functionality to peptide-related research. AnaSpec is pleased to offer custom synthesis for hydrocarbon-stapled peptides. Hydrocarbon-stapled peptides are peptides capable of forming stable alpha helical structure... - June 20, 2008 - AnaSpec, Inc.

AnaSpec has introduced a new series of IHC validated antibodies, Anti-CARMA/CARD/Bimp antibodies. CARMA proteins are scaffold molecules that belong to the membrane-associated guanylate kinase-like (MAGUK) and the caspase-associated recruitment domain (CARD) protein families. They play critical role... - June 19, 2008 - AnaSpec, Inc.

This week AnaSpec, a world leader in custom and catalog peptides, introduced eleven (11) new peptides. - June 18, 2008 - AnaSpec, Inc.

Genomic Nanosystems, LLC has received the exclusive patent rights to U.S. patent No. 6,143,496. Patent ‘496 was first to describe methods for detecting single nucleic acid molecules after one amplification step, for amplifying one or more nucleic acids in nano-scale volumes or regions, and for carrying out digital PCR. - June 01, 2008 - Genomic Nanosystems

AnaSpec has introduced the SensoLyte™ 520 Cathepsin S Assay Kit to its broad collection of long wavelength FRET protease assay kits. - May 29, 2008 - AnaSpec, Inc.

This week, AnaSpec introduced sixty (60) new catalog peptides and three (3) new assay kits. - May 27, 2008 - AnaSpec, Inc.

The Tampa-based CRO and its chief executive are voted as best company and CEO of the year. - May 26, 2008 - Xcelience, LLC

AnaSpec added eight (8) new antibody products to its growing collection. - May 24, 2008 - AnaSpec, Inc.

AnaSpec has introduced ClearPoint™ Peptides, heavy isotope-labeled peptides for absolute quantitation (AQUA) of proteins. - May 18, 2008 - AnaSpec, Inc.

The Tampa-based CRO continues its perpetual growth with new XRD support. - May 08, 2008 - Xcelience, LLC

The number of published papers that cite AnaSpec’s products has passed 600. - May 04, 2008 - AnaSpec, Inc.

AnaSpec presented its latest findings in regards to the detection of TACE activity using FRET technology. - May 03, 2008 - AnaSpec, Inc.

AnaSpec has introduced a full suite of phospho-specific ErbB-2 (Her-2) polyclonal antibodies. - April 30, 2008 - AnaSpec, Inc.

AnaSpec added thirteen (13) new antibody products to its growing collection. - April 25, 2008 - AnaSpec, Inc.

AnaSpec’s SensoLyte™ line of MMP assay kits have quickly become the new standard in MMP assay sensitivity. - April 24, 2008 - AnaSpec, Inc.

AnaSpec FRET-based MMP substrates were recently used in a double differential in vivo zymography study at the University of New Brunswick. - April 23, 2008 - AnaSpec, Inc.

AnaSpec has introduced its newest MMP antibodies. - April 11, 2008 - AnaSpec, Inc.